返回 Agenda
Session Chair(s)
Henk van den Berg, DrMed, PHD
Member Paediatric Committee
Medicines Evaluation Board, Netherlands
Max Wegner, PHARMD, RPH
Head Regulatory Affairs
Bayer AG, Germany
Speaker(s)
Mechanism of Action- The leading line
Daniel Brasseur, DrMed
Federal Agency for Medicines Health Products (FAMHP), Belgium
PDCO Chairman
Model PIPs in Oncology- The way forward?
Henk van den Berg, DrMed, PHD
Medicines Evaluation Board, Netherlands
Member Paediatric Committee
Clinical Development in Oncology – How to draft the PIP?
Raphaël Rousseau, MD, PHD
Gritstone Oncology, Inc., United States
Executive Vice President and Chief Medical Officer